Biocon Biologics and Adagio Therapeutics to develop antibody treatment for COVID-19
Biocon Biologics to manufacture and commercialise a broadly neutralising antibody for India and select emerging markets
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.